Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robberecht

Showing results (471-480 of 651) with videos related to

Pageof 66
Sort By:
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trialsVincent Meininger, Gilbert Bensimon, Walter R Bradley, et al.
Pharmacological Research Communications|June 1, 1985
Skin penetration of minerals in psoriatics and guinea-pigs bathing in hypertonic salt solutionsJ Shani, S Barak, D Levi, et al.
Peptides|January 1, 1986
Effector mechanisms of peptides of the VIP familyJ Christophe, M Svoboda, M Lambert, et al.
Leukemia|August 1, 1993
Mixed phenotype murine leukemiasM P Defresne, B Borremans, C Verhofstede, et al.
Neurobiology of Aging|July 23, 2013
Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort studySarah Debray, Valérie Race, Veerle Crabbé, et al.
Pancreas|January 1, 1988
Secretin receptors in human pancreatic membranesP Robberecht, P De Neef, M Waelbroeck, et al.
Human Molecular Genetics|July 20, 2007
Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafishRobin Lemmens, Annelies Van Hoecke, Nicole Hersmus, et al.
Neurobiology of Aging|February 3, 2009
VEGF protects motor neurons against excitotoxicity by upregulation of GluR2Elke Bogaert, Philip Van Damme, Koen Poesen, et al.
European Journal of Pharmacology|February 15, 1995
Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cellsE Ciccarelli, M Svoboda, P De Neef, et al.
FEBS Letters|July 29, 1991
The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1-27) and PACAP (1-38)) interact with distinct receptors on rat pancreatic AR 4-2J cell membranesP Robberecht, M C Woussen-Colle, P De Neef, et al.
Pageof 66

Showing results (471-480 of 651) with videos related to

Sort By:
Pageof 66
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trialsVincent Meininger, Gilbert Bensimon, Walter R Bradley, et al.
Pharmacological Research Communications|June 1, 1985
Skin penetration of minerals in psoriatics and guinea-pigs bathing in hypertonic salt solutionsJ Shani, S Barak, D Levi, et al.
Peptides|January 1, 1986
Effector mechanisms of peptides of the VIP familyJ Christophe, M Svoboda, M Lambert, et al.
Leukemia|August 1, 1993
Mixed phenotype murine leukemiasM P Defresne, B Borremans, C Verhofstede, et al.
Neurobiology of Aging|July 23, 2013
Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort studySarah Debray, Valérie Race, Veerle Crabbé, et al.
Pancreas|January 1, 1988
Secretin receptors in human pancreatic membranesP Robberecht, P De Neef, M Waelbroeck, et al.
Human Molecular Genetics|July 20, 2007
Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafishRobin Lemmens, Annelies Van Hoecke, Nicole Hersmus, et al.
Neurobiology of Aging|February 3, 2009
VEGF protects motor neurons against excitotoxicity by upregulation of GluR2Elke Bogaert, Philip Van Damme, Koen Poesen, et al.
European Journal of Pharmacology|February 15, 1995
Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cellsE Ciccarelli, M Svoboda, P De Neef, et al.
FEBS Letters|July 29, 1991
The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1-27) and PACAP (1-38)) interact with distinct receptors on rat pancreatic AR 4-2J cell membranesP Robberecht, M C Woussen-Colle, P De Neef, et al.
Pageof 66